Author(s):
Manvini. S, Pinki Verma
Email(s):
vermapinki05@gmail.com
DOI:
10.52711/2231-5691.2026.00025 
Address:
Manvini. S1, Pinki Verma2*
1Research Scholar, Department of Pharmacology, Aditya Bangalore Institute of Pharmacy Education and Research, Rajiv Gandhi University of Health Sciences, Yelahanka, Bengaluru, 560064 Karnataka, India.
2Associate Professor, Department of Pharmacology, Aditya Bangalore Institute of Pharmacy Education and Research, Rajiv Gandhi University of Health Sciences, Yelahanka, Bengaluru, 560064 Karnataka, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2026
ABSTRACT:
Phyllanthus emblica L., also recognized as Indian gooseberry or Amla, is a time-honored medicinal plant in Ayurveda, traditionally acclaimed for promoting vitality, digestion, and longevity. Owing to its rich composition of biologically active constituents—such as emblicanin A and B, ellagic acid, gallic acid, and flavonoids—this plant has been found to exhibit significant pharmacological properties, including antioxidant, anti-inflammatory, and immunomodulatory effects. With the evolving focus of translational medicine on applying laboratory research to clinical contexts, P. emblica has emerged as a promising candidate for multi-target therapeutic development. This review offers a cross-disciplinary synthesis of traditional Ayurvedic principles and recent biomedical findings to evaluate the medicinal relevance of P. emblica in modern healthcare. Scientific investigations have demonstrated its capability to regulate key molecular pathways such as NF-?B, MAPK, and PI3K/Akt, underscoring its potential in addressing a variety of complex disorders, including metabolic syndromes, neurodegenerative diseases, liver dysfunctions, and certain cancers. Furthermore, its influence on gut microbiota and immune system modulation offers new insights into its systemic benefits. Recent advancements in pharmaceutical technologies, including nanoformulations and phytosome-based delivery systems, have enhanced the bioavailability and targeted efficacy of its active compounds. Findings from clinical studies further confirm the safety and therapeutic viability of P. emblica, facilitating its transition from traditional herbal use to scientifically validated medicine. This article aims to bridge ancestral herbal knowledge with contemporary research by exploring the phytochemistry, molecular mechanisms, and clinical applications of P. emblica. It concludes with a discussion on current research limitations and prospects, highlighting the need for integrative, systems-biology-driven investigations. In doing so, it positions P. emblica as a pivotal natural agent in the landscape of personalized and integrative medicine.
Cite this article:
Manvini. S, Pinki Verma. Phyllanthus emblica in the Era of Translational Medicine: Unveiling its Multitargeted Therapeutic Arsenal from Ayurveda to Advanced Biomedicine. Asian Journal of Pharmaceutical Research. 2026; 16(2):163-2. doi: 10.52711/2231-5691.2026.00025
Cite(Electronic):
Manvini. S, Pinki Verma. Phyllanthus emblica in the Era of Translational Medicine: Unveiling its Multitargeted Therapeutic Arsenal from Ayurveda to Advanced Biomedicine. Asian Journal of Pharmaceutical Research. 2026; 16(2):163-2. doi: 10.52711/2231-5691.2026.00025 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2026-16-2-10
REFERENCES:
1. Bashir Ahmad, Nabia Hafeez, Abdur Rauf, Shumaila Bashir, Huang Linfang, Mujeeb-ur Rehman, Mohammad S. Mubarak, Md. Sahab Uddin, Saud Bawazeer, Mohammad Ali Shariati, Maria Daglia, Chunpeng Wan, Kannan RR Rengasamy, Phyllanthus emblica: A comprehensive review of its therapeutic benefits, South African Journal of Botany 2021; 138: 278-310. https://doi.org/10.1016/j.sajb.2020.12.028
2. Bonthu VAD, Vatchavai B, Kunche TL, Konala JSP, Shaik S, Sattineedi P, Seelamsetti D. Phytoconstituents and pharmacological activities of Phyllanthus emblica. Int J Pharm Sci. 2024; 2(12): 1975-1986. doi:10.5281/zenodo.14462949
3. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Front Pharmacol. 2023 Oct 26; 14:1288618. doi:10.3389/fphar.2023.1288618. PMID: 37954853; PMCID: PMC10637531.
4. Naila H Alkefai, Aayeena Altaf, Zeeshan Altaf, Mir Khanam and Afshana Khan. Medicinal and Therapeutic Potential of Phyllanthus emblica (Amla-Indian Gooseberry): A Review Journal of Nutrition and Food .2023;13( 3)1-4. DOI: 10.35248/2155-9600.23.13.021
5. Saini R, Sharma N, Oladeji OS, Sourirajan A, Dev K, Zengin G, El-Shazly M, Kumar V. Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review. Journal of Ethnopharmacology. 2022; 282: 114570. doi: 10.1016/j.jep.2021.114570.
6. Swathi V, Suresh Kumar JN, Dharani Prasad P, Salma S, Rani M, Aslam SA, Tipsy K. A Review on Phyllanthus emblica: Antiinflamatory and Antioxidant Effect. Uttar Pradesh Journal of Zoology. 2023; 44(6): 23–32. DOI: 10.56557/UPJOZ/2023/v44i63451.
7. Vijaya Ambica Durga Bonthu, Bhaskararaju Vatchavai, Tejasri Lakshmi Kunche, Jyothsna Satya Priya Konala, Shafiya Shaik, Pujitha Sattineedi, Dhanusree. Phytoconstituents And Pharmacological Activities of Phyllanthus emblica. International Journal of Pharmaceutical Sciences. 2024; 2(12): 1975-1986. DOI: 10.5281/zenodo.14462949.
8. Gaire BP, Subedi L. Phytochemistry, pharmacology and medicinal properties of Phyllanthus emblica Linn. Chin J Integr Med. 2014 Dec 9. doi: 10.1007/s11655-014-1984-2. Epub ahead of print. PMID: 25491539.
9. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Front Pharmacol. 2023; 14: 1-20.doi:10.3389/fphar.2023.1288618. PMID: 37954853; PMCID: PMC10637531.
10. Singh E, Sharma S, Pareek A, Dwivedi J, Yadav S, Sharma S. Phytochemistry, traditional uses and cancer chemopreventive activity of Amla (Phyllanthus emblica): The Sustainer. Journal of Applied Pharmaceutical Science. 2011; 2(1): 176-83.
11. S.M. Moazzem Hossen, Mohi Uddin and Md. Raihan Sarkar. Medicinal potential of Phyllanthus emblica (Linn.) fruits extracts: biological and pharmacological activities. International Journal of Pharmacognosy. 2014; 1(5): 307-316. DOI: http://dx.doi.org/10.13040/IJPSR.0975-8232.IJP.1(5).307-16
12. Lanka S. A review on pharmacological, medicinal and ethnobotanical important plant: Phyllanthus emblica linn.(syn. Emblica officinalis). World Journal of Pharmaceutical Research. 2018; 7(4): 380-96. DOI:10.20959/wjpr20184-11103
13. Perianayagam JB, Sharma SK, Joseph A, Christina AJ. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. Journal of Ethnopharmacology. 2004; 95(1): 83-85. DOI: 10.1016/j.jep.2004.06.020
14. Abdel-Hady H, Morsi EA, El-Wakil EA. In-vitro antimicrobial potentialities of Phyllanthus emblica leaf extract against some human pathogens. Egyptian Journal of Chemistry. 2022; 65(7): 701–707.doi:https://doi.org/10.21608/ejchem.2021.109577.4998
15. 15.Zhang YJ, Abe T, Tanaka T, Yang CR, Kouno I. Phyllanemblinins A−F, New Ellagitannins from Phyllanthus emblica. Journal of Natural Products. 2001; 64(12): 1527–1532. DOI: 10.1021/np010370g
16. Asmilia N, Yudha F, Abrar M, Rinidar R. Chemical compounds of Malacca leaf (Phyllanthus emblica) after triple extraction with N-hexane, ethyl acetate and ethanol. Hindawi. 2020. https://doi.org/10.1155/2020/2739056.
17. Mohamed TS, Refahya LA, Romeihb MH, Hameda MM, Ahmedb HO, El-Hashash MA. Chromatographic isolation and characterization of certain bioactive chemical ingredients of Phyllanthus emblica extracts and assessment of their potentials as antiviral and anticancer agents. Egyptian Journal of Chemistry. 2022; 65(1): 179–192.
18. Zhang YJ, Abe T, Tanaka T, Yang CR, Kouno I. Two new acylated flavanone glycosides from the leaves and branches of Phyllanthus emblica. Chemical and Pharmaceutical Bulletin. 2002; 50(6): 841–843.
19. Chaphalkar R, Apte KG, Talekar Y, Ojha SK, Nandave M. Antioxidants of Phyllanthus emblica L. Bark Extract Provide Hepatoprotection against Ethanol-Induced Hepatic Damage: A Comparison with Silymarin. Oxid Med Cell Longev. 2017; 2017: 3876040. doi: 10.1155/2017/3876040.
20. Saikat Gantait, Manisha Mahanta, Soumen Bera, Sandeep Kumar Verma. Biotech. 2021; 11(2): 62. https://doi.org/10.1007/s13205-020-02615-5
21. Halim B, Syahputra RA, Adenin I, Lubis HP, Mendrofa F, Lie S, Nugraha SE. Determination of phytochemical constituent, antioxidant activity, total phenol and total flavonoid of extract ethanol Phyllanthus emblica fruit. Pharmacognosy Journal. 2022; 14(1): 63-67.
22. Liu X, Cui C, Zhao M, Wang J, Luo W, Yang B, Jiang Y. Identification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities. Food chemistry. 2008; 109(4): 909-15.
23. Sriwatcharakul S. Evaluation of bioactivities of Phyllanthus emblica seed. Energy Reports. 2020 Feb 1; 6:442-7.
24. Nambiar SS, Paramesha M, Shetty NP. Comparative analysis of phytochemical profile, antioxidant activities and foam prevention abilities of whole fruit, pulp and seeds of Emblica officinalis. Journal of Food Science and Technology. 2015 Nov; 52: 7254-62.
25. Balkrishna A, Verma S, Joshi M, Tomer M, Gohel V, Nain P, Dev R, Varshney A. Comprehensive phytochemical profiling of Phyllanthus emblica L. flowers on UHPLC/MS quadrupole time of flight, HPTLC, HPLC, and NMR analytical platforms reveals functional metabolites with potent anti-inflammatory effects in human (THP1) macrophages. Phytochemical Analysis. 2025 Jan.
26. Liu X, Zhao M, Wang J, Yang B, Jiang Y. Antioxidant activity of methanolic extract of emblica fruit (Phyllanthus emblica L.) from six regions in China. Journal of Food Composition and Analysis. 2008; 21(3): 219-28.
27. Tahir I, Khan MR, Shah NA, Aftab M. Evaluation of phytochemicals, antioxidant activity and amelioration of pulmonary fibrosis with Phyllanthus emblica leaves. BMC Complementary and Alternative Medicine. 2016 Dec; 16:1-2.
28. 28S. Shanthi, M. Sahina Begum, M.Senthuja. In- vitro Antioxidant and Anti-aging activity of a Traditional Ayurvedic Formulation. Research Journal of Pharmacy and Technology. 2023; 16(8): 3521-4. doi: 10.52711/0974-360X.2023.00581.
29. Moorthy SR, Kumar SS, Devandaran K, Anguchamy S, Ragunathan R, Johney J. Evaluation of the Antimicrobial, Antioxidant, and Cytotoxicity Against MCF-7 Breast Cancer Cell Lines of Phyllanthus emblica L. Bark Extract. Journal of Natural Remedies. 2024: 24(5): 1091-7.
30. Mahata S et al. Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutrition and Cancer. 2013; 65(1): 88-97.
31. Zhang YJ, Nagao T, Tanaka T, Yang CR, Okabe H, Kouno I. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biological and Pharmaceutical Bulletin. 2004; 27(2): 251-5.
32. Díaz-Herrera TH, Caldas Martínez ML, Coy-Barrera E. Phyllanthus-Derived Naturally-Occurring Products: An Overview of Their Effects against Viruses in Cell Models. Current Bioactive Compounds. 2024; 20(9): 1-26.
33. Lunavath V, Mamidala E. Studies on anti-HIV activity of Phyllanthus emblica plant extracts. The Bioscan. 2012; 7(3): 451-4.
34. Jeevangi S, Manjunath S, Sakhare PM. A study of anti-hyperlipidemia, hypolipidemic and anti-atherogenic activity of fruit of Emblica officinalis (amla) in high fat fed albino rats. International Journal of Medical Research and Health Sciences. 2013; 1(2): 70-7.
35. Variya BC, Bakrania AK, Chen Y, Han J, Patel SS. Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety. Biomedicine and Pharmacotherapy. 2018; 108: 1274-81.
36. Li W, Zhu HW, Chen YJ, Xiao H, Ge YZ, Hu HE, Li XL, Cao Y. Bioactivity‐guided isolation of anti‐inflammatory components from Phyllanthus emblica. Food Science and Nutrition. 2020; 8(6): 2670-9.
37. 37Sanakousar K. Patel, Arun K Shutter, Ria Patil, Archana Desangi, Vishalakshi Malali, Jyoti Patil, Sumangala Patil, Kusal K. Das, Prachi P. Parvatikar. In-Vitro Antioxidant, Anti-Inflammatory and Cytotoxic effects of different Solvent Extraction Terminalia chebula, Terminalia billerica, Phyllanthus emblica. Research Journal of Pharmacy and Technology. 2022; 15(7): 2940-4. doi: 10.52711/0974-360X.2022.00490
38. Srinivasan P, Vijayakumar S, Kothandaraman S, Palani M. Anti-diabetic activity of quercetin extracted from Phyllanthus emblica L. fruit: In silico and in vivo approaches. Journal of Pharmaceutical Analysis. 2018; 8(2):109-18.
39. Sultana Z, Jami SI, Ali E, Begum M, Haque M. Investigation of antidiabetic effect of ethanolic extract of Phyllanthus emblica Linn. fruits in experimental animal models. Pharmacology and Pharmacy. 2014;5(1):11-8.
40. Ayuwardani N, Sofro ZM, Fakhrudin N, Ikawati Z. Antioxidant and Neuroprotective Activities of Phyllanthus emblica L: A Review. Tropical Journal of Natural Product Research. 2024;8(10):8617-8628.
41. Spoorthi. N, Pinki Verma, Hemavathi. N. Amelioration of Antipsychotic Activity of Ethanolic Fruit Extract of Piper longum and its effects on TNF-α Expression in Rat Hippocampus. Research Journal of Pharmacy and Technology. 2024; 17(9):4214-0. doi: 10.52711/0974-360X.2024.00651
42. Jaijoy K, Soonthornchareonnon N, Lertprasertsuke N, Panthong A, Sireeratawong S. Acute and chronic oral toxicity of standardized water extract from the fruit of Phyllanthus emblica Linn. International Journal of Applied Research in Natural Products. 2010; 3(1): 48-58.
43. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Frontiers in Pharmacology. 2023; 14: 1288618. doi: 10.3389/fphar.2023.1288618. PMID: 37954853; PMCID: PMC10637531.
44. Priya FF, Islam MS. Phyllanthus emblica Linn. (Amla)—a natural gift to humans: an overview. Journal of Diseases and Medicinal Plants. 2019; 5:1-9.
45. Usharani P, Merugu PL, Nutalapati C. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: A randomised, double blind, placebo controlled clinical study. BMC Complementary and Alternative Medicine.2019; 19: 1-8.
46. Charoenteeraboon J, Ngamkitidechakul C, Soonthornchareonnon N, Jaijoy K, Sireeratawong S. Antioxidant activities of the standardized water extract from fruit of Phyllanthus emblica Linn. Sonklanakarin Journal of Science and Technology. 2010; 32(6): 599-604.
47. 47.Jaijoy, K., et al. Anti-inflammatory and analgesic activities of the water extract from the fruit of Phyllanthus emblica Linn. International Journal of Applied Research in Natural Products. 2010: 28-35.
48. 48.Yin K, Li X, Luo X, Sha Y, Gong P, Gu J, Tan R. Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon‐ Tetrachloride‐Induced Liver Fibrosis in Rats. Evidence‐Based Complementary and Alternative Medicine. 2021; 2021(1): 5345821.
49. B Halim, RA Syahputra, I Adenin, HP Lubis, F Mendrofa, S Lie, SE Nugraha. Determination of phytochemical constituent, antioxidant activity, total phenol and total flavonoid of extract ethanol Phyllanthus emblica fruit. Pharmacognosy Journal. 2022; 14(1): 63-67. doi:10.5530/pj.2022.14.9
50. Jahan N, Akter S. Assessment of the antimicrobial activity of the ethanolic extract of Phyllanthus emblica in combination with different classes of antibiotics against single and multi-drug-resistant strains. Journal of Pharmacognosy and Phytochemistry. 2015; 4(4): 142-155.
51. Hemavathi N, Pinki Verma, Spoorthi N. Antidepressant and Antioxidant Activity of Ethanolic Extract of Evolvulus alsinoides Leaves and its effect on TNF-α Expression in Mice Hippocampus. Research Journal of Pharmacy and Technology. 2025; 18(4): 1551-6. doi: 10.52711/0974-360X.2025.
52. Rakesh Manna, Pinki Verma. A Review on Saraca indica – for Immunomodulatory Activity. Asian Journal of Pharmacy and Technology. 2023; 13(2): 135-8. doi: 10.52711/2231-5713.2023.00025
53. Hossain MM, Hamza A, Polash SA, Tushar MH, Takikawa M, Piash AB, Dekiwadia C, Saha T, Takeoka S, Sarker SR. Green synthesis of silver nanoparticles using Phyllanthus emblica extract: Investigation of antibacterial activity and biocompatibility in vivo. RSC Pharmaceutics. 2024; 1(2): 245-58.
54. Thoidingjam S, Tiku AB. Therapeutic efficacy of Phyllanthus emblica-coated iron oxide nanoparticles in A549 lung cancer cell line. Nanomedicine (Lond). 2019 Sep; 14(17): 2355-2371. doi: 10.2217/nnm-2019-0111. Epub 2019 Aug 15. PMID: 31414606.
55. Wang R, Xu X, Puja AM, Perumalsamy H, Balusamy SR, Kim H, Kim YJ. Gold Nanoparticles Prepared with Phyllanthus emblica Fruit Extract and Bifidobacterium animalis subsp. lactis Can Induce Apoptosis via Mitochondrial Impairment with Inhibition of Autophagy in the Human Gastric Carcinoma Cell Line AGS. Nanomaterials (Basel). 2021; 11(5): 1260. doi: 10.3390/nano11051260.
56. Ramezani, H., Sazegar, H. and Rouhi, L. Chitosan-casein as novel drug delivery system for transferring Phyllanthus emblica to inhibit Pseudomonas aeruginosa. BMC Biotechnology. 2024; 24: 101. https://doi.org/10.1186/s12896-024-00907-9.
57. Masfria, Sumaiyah, syahputra, h., and silvia. Antibacterial and anti-inflammatory activities of nanosimplicia phyllantus emblica l. fruit in suspension formulation. International Journal of Applied Pharmaceutics. 2025; 17(2); 376–383. https://doi.org/10.22159/ijap.2025v17i2.52608.
58. G. Patel, R. Sorake and N. Pai A Randomized Single Blind Placebo Controlled Clinical Study to Evaluate Efficacy of Amalaki (Emblica Officinalis) Extract Capsule on Acne Vulgaris Along with Its anti-oxidant Property. International Journal OF Pharmaceutical Sciences and Research. 2021; 12(7): 3832-3838. doi: 10.13040/IJPSR.0975-8232.12(7).3832-38
59. Acampado LRT, Chiu HHC, Larrazabal RB Jr, Arcellana AES, Añonuevo-Cruz MCS. The Efficacy and Safety of Emblica officinalis Aqueous Fruit Extract among Adult Patients with Dyslipidemia: A Systematic Review and Meta-analysis. Acta Med Philipp.2023 ;29; 57(5): 90-95. doi: 10.47895/amp.vi0.5047.
60. Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013; 26(6): 275-84. doi: 10.2147/DMSO.S46341.
61. Prananda AT, Dalimunthe A, Harahap U, Simanjuntak Y, Peronika E, Karosekali NE, Hasibuan PAZ, Syahputra RA, Situmorang PC, Nurkolis F. Phyllanthus emblica: a comprehensive review of its phytochemical composition and pharmacological properties. Front Pharmacol. 2023; 14: 1-20. doi:10.3389/fphar.2023.1288618.
62. Geethika, E., Ramamoorthy, S. and Ravikanth, G. Does long-term harvesting impact genetic diversity and population genetic structure? A study of Indian gooseberry (Phyllanthus emblica) in the Central Western Ghats region in India. Plant Syst Evol. 2024; 310.https://doi.org/10.1007/s00606-024-01906-1.
63. Tiejun Zhao et al, Anticancer Properties of Phyllanthus emblica (Indian Gooseberry) Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity. 2015; 1-7. http://dx.doi.org/10.1155/2015/950890.
64. Tiana M, Kusuma ASW, Shanmuganathan K. Antibacterial activity of Phyllanthus emblica against Bacillus cereus and Shigella dysenteriae. Asian J Pharm Clin Res. 2017.
65. Masfria S, Sumaiyah, Hafid Syahputra, Silvia. Antibacterial and anti-inflammatory activities of nanosimplicia Phyllanthus emblica L. fruit in suspension formulation. Int J Appl Pharm. 2025.
66. Raj M, Vyas GK, Sharma S, Sharma A. Phytoanalysis and formulation of herbal lotion containing Phyllanthus emblica. Asian J Pharm Res Dev. 2022.
67. Chaiyasut C, Sivamaruthi BS, et al. Assessment of the biological safety of fermented Phyllanthus emblica fruit juice. Asian J Pharm Clin Res. 2018.
68. Md Monir Hossain et al]. Green synthesis of silver nanoparticles using Phyllanthus emblica extract: investigation of antibacterial and antifungal activity. Int J Appl Pharm. 2024; 16(2): 1-6..
69. Masihuddin; Jafri MA; Siddiqui A; Chaudhary S. Traditional uses, phytochemistry, and pharmacological activities of amla with special reference of Unani medicine: an updated review. Asian J Pharm Clin Res. 2019; 12(2): 70–74. doi:10.22159/ajpcr. 2019.v12i2.29178.
70. Pawar DB, et al. Antidepressant activity of aqueous extracts of fruits of Terminalia chebula and Phyllanthus emblica. Int J Pharm Pharm Sci. 2014.
71. Bhandari PR, Kamdod MA. Emblica officinalis (Amla): a review of potential therapeutic applications. Int J Green Pharm. 2012; 6(4): 257–269. doi:10.4103/0973-8258.108204
72. Hassan SM, Mughal SS, Aslam A, Mushtaq M, Munir M, Pervez S, Shabbir N, Ayub AR, Farman M. Emblica officinalis (Amla): A prospective review on distinctive properties and therapeutic applications of Amla. Innovare J Ayurvedic Sci. 2020; 8(3): 1–6.